NCBiotech News

Two speakers at this week's NCBiotech Ag Biotech Professional Forum described how their companies are harnessing peptides and metabolites to boost the innate immune response in plants.

The Johnston County Workforce Center (JCWC) will be getting a $1.3 million renovation. Upgrades will support the skills needed with the expansions being done at Grifols and Novo Nordisk to name a few.

Since the center’s grand opening in 2005, it has been a model for life sciences training and development centers in North Carolina. The updates being done will help keep up with the emerging opportunities in the life science field.

Asklepios BioPharmaceutical (AskBio), a gene therapy platform company based in Chapel Hill, has spun out its fourth company, Actus Therapeutics, to develop gene therapies for rare genetic diseases including Pompe disease and epilepsy.

Why is the U.S. Department of Defense Advanced Research Projects Agency (DARPA) interested in agriculture? 

North Carolina entrepreneurs looking to validate and advance their business startup ideas are being encouraged to apply now through May 14 for NC IDEA’s new “no strings attached” SEED Micro-Grant Pilot Program.

Morrisville-based Metabolon, a metabolomics company, will analyze biomarkers of wellness and disease in U.S. veterans through the Million Veteran Program (MVP) of the U.S. Department of Veterans Affairs.

Worldwide Clinical Trials of Morrisville has formed a strategic alliance with KinderPharm of Exton, Pa., to create what the two clinical research organizations (CROs) are calling the world’s first center of excellence for pediatric drug development and clinical research for the pharmaceutical industry.

Cambrex Corp., a contract manufacturer of small molecules and active pharmaceutical ingredients (APIs) for drug clinical trials, is expanding again in High Point to meet growing business demand for its services.

Grifols, a Spanish biotherapeutics company that employs some 2,500 people in North Carolina, donated more than 25 million international units (IU) of blood clotting factor in 2017, as part of an eight-year commitment to changing the lives of people with hemophilia in 47 countries who have limited access to treatment.

​​​​​​​Good timing had a lot to do with the success of FoodLogiQ, the Durham-based software as a service (SaaS) provider of food traceability, safety and supply chain transparency, says co-founder Andrew Kennedy.

Camras Vision, an NCBiotech portfolio company developing a new medical device for treating glaucoma, has closed on $5.7M in equity funding in a Series A round.

Camras Vision, developer of a new medical device for treating glaucoma, won the Emerging Company Award at SEBIO’s 19th Annual Investor and Partnering Forum in Pinehurst. The honor came a few days before the company expects to close on $5 million in Series A financing.

Biovet S.A. Laboratories, a Spanish animal-nutrition company, has established a small office in Research Triangle Park to better serve the North American market.

Two North Carolina medical technology companies are among the six chosen to pitch their wares next Monday, April 9, during the inaugural Southeast Region Pitch Event at the North Carolina Biotechnology Center.

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy and Fast Track designations to Fennec Pharma’s drug designed to protect the hearing of children undergoing chemotherapy.